Clinical trial
Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
NCT00165763 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00165763 |
|---|---|
| Title | Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia |
| Official title | An Open Label Study on the Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | Eisai Co., Ltd. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Vascular Dementia |
| Intervention type | Drug |
| Interventions | donepezil hydrochloride (Aricept) |
| Enrollment | 36 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2009 |
| First posted | Sep 14, 2005 |
| Last update posted | May 4, 2012 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: